NEWARK, Del, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The continuous peripheral nerve block catheter market is estimated to be worth US$ 585.6 million in 2023 and projected to be valued at US$ 1,058.6 ...
The Continuous Peripheral Nerve Block Catheter Market is predicted to grow at a 6.1% CAGR and is projected to reach US$ 742.7 million By 2027 from an estimated US$ 411 million in 2017. Future Market ...
WOLF CREEK, MT / ACCESSWIRE / February 22, 2022 / Solo-Dex, Inc. today announced a national distribution agreement for its proprietary continuous peripheral nerve block catheters with InfuSystem ...
This report by Future Market Insights (FMI) examines the “Continuous Peripheral Nerve Block Catheter market” for the period 2017–2027. The primary objective of the report is to offer updates and ...
In both studies, Exparel achieved a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine hydrochloride. The Food and Drug Administration (FDA) has ...
ORLANDO, Fla. — Suprascapular nerve block has been shown efficacious in both outpatient shoulder arthroscopy and inpatient shoulder surgery. In addition, the technique avoids some of the problems ...
Please provide your email address to receive an email when new articles are posted on . According to published results, peripheral nerve blocks may effectively reduce postoperative pain in patients ...
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback